JYHZ2400312 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2024-11-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp | | | view |
CYHS2400006 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2024-01-03 | | Anruowita Pharmaceutical Taizhou Co Ltd | | | view |
CYHS2101030 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-03-22 | | Beijing Foyou Pharma Co Ltd | | | view |
CYHB2300351 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-02-21 | | Anhui JieXi Pharmaceutical Co Ltd;Hefei Cosource Heyuan Pharmaceutical Co Ltd | | | view |
CYHS2501847 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-22 | | Jiangsu Vanguard Pharmaceutical Co Ltd | | | view |
JXHL1000024 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Import Drug Application | 2010-01-27 | | Bristol-Myers Squibb Company | Certificate Issued | 2011-09-19 | view |
JYHZ2400314 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2024-11-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp | | | view |
CYHS2101149 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-13 | | Hefei Cosource Heyuan Pharmaceutical Co Ltd | | | view |
JYHZ2400313 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2024-11-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp | | | view |
JXHL1000025 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Import Drug Application | 2010-01-27 | | Bristol-Myers Squibb Company | Certificate Issued | 2011-09-19 | view |
CYHS2402391 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2024-07-30 | | Zhejiang Hacon Pharmaceutical Co Ltd | | | view |
CYHS2101031 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-03-22 | | Beijing Foyou Pharma Co Ltd | | | view |
JYHZ2400315 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2024-11-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp | | | view |
CYHS2402390 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs(4) | Generic Drug | 2024-07-30 | | Zhejiang Hacon Pharmaceutical Co Ltd | | | view |
JXHL1000172 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Import Drug Application | 2010-06-03 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2011-05-17 | view |
JYHB1301211 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Supplementary Application | 2013-10-10 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2014-05-29 | view |
JYHB1100695 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Supplementary Application | 2011-08-04 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2012-03-13 | view |
JYHB1100694 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Supplementary Application | 2011-08-04 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2012-03-13 | view |
JXHL1000171 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Import Drug Application | 2010-06-07 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2011-05-17 | view |
JYHB1301212 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Supplementary Application | 2013-10-10 | Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | Certificate Issued | 2014-05-29 | view |